000 01526 a2200409 4500
005 20250517192439.0
264 0 _c20180608
008 201806s 0 0 eng d
022 _a1471-230X
024 7 _a10.1186/s12876-017-0726-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAlonso, Sonia
245 0 0 _aUpcoming pharmacological developments in chronic hepatitis B: can we glimpse a cure on the horizon?
_h[electronic resource]
260 _bBMC gastroenterology
_cDec 2017
300 _a168 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntiviral Agents
_xadverse effects
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aDNA, Circular
_xantagonists & inhibitors
650 0 4 _aDNA, Viral
_xantagonists & inhibitors
650 0 4 _aGene Expression
_xdrug effects
650 0 4 _aHepatitis B Surface Antigens
_xdrug effects
650 0 4 _aHepatitis B virus
_xdrug effects
650 0 4 _aHepatitis B, Chronic
_xdrug therapy
650 0 4 _aHost-Pathogen Interactions
650 0 4 _aHumans
650 0 4 _aLife Cycle Stages
650 0 4 _aVirus Attachment
_xdrug effects
650 0 4 _aVirus Replication
_xdrug effects
700 1 _aGuerra, Adriana-René
700 1 _aCarreira, Lourdes
700 1 _aFerrer, Juan-Ángel
700 1 _aGutiérrez, María-Luisa
700 1 _aFernandez-Rodriguez, Conrado M
773 0 _tBMC gastroenterology
_gvol. 17
_gno. 1
_gp. 168
856 4 0 _uhttps://doi.org/10.1186/s12876-017-0726-2
_zAvailable from publisher's website
999 _c27916200
_d27916200